Logo

American Heart Association

  11
  0


Final ID: P-151

National Estimates of Lifetime Risk of Hypertension in the US

Abstract Body: Background: Although lifetime risk assessments provide valuable insights into disease burden, to our knowledge, there is only one study estimating the lifetime risk of hypertension in the US, using the current definition (≥130/80 mmHg). However, that study used data from three research cohorts not representative of the US population and lacks data on Hispanics.
Aim: To estimate lifetime risk of hypertension in the US, using the contemporary definition and nationally representative data.
Methods: Using the National Health and Nutrition Examination Survey 1999-2018 (N=44,056) and vital statistics, we estimated the prevalence and incidence of hypertension (i.e., ≥130/80 mmHg or antihypertensive medication use) at each year of age from birth to age 80 years) by sex and race/ethnicity (Whites, Blacks, and Hispanics). We, then, estimated the cumulative incidence of hypertension up to 80 years using Monte Carlo simulations.
Results: The lifetime risk of hypertension reached ~80-85% regardless of sex and race/ethnicity (Figure). However, the patterns of reaching this level of lifetime risk of hypertension varied considerably by race/ethnicity, with the age reaching the cumulative incidence of 50% ~40 years in Blacks vs. ~50 years in Whites and Hispanics. Black women exhibited a higher cumulative incidence of hypertension than White and Hispanic men at any point in life.
Conclusions: Four in five Americans develop hypertension in their lifetime, regardless of sex and race/ethnicity. However, Blacks develop hypertension much earlier than Whites and Hispanics. These findings emphasize the need for public health interventions to prevent hypertension in the US, and such an intervention should reach Black youth and younger adults.
  • Rayani, Asma  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Mok, Yejin  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Matsushita, Kunihiro  ( Johns Hopkins Bloomberg School of Public Health , Baltimore , Maryland , United States )
  • Appel, Lawrence  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Author Disclosures:
    Asma Rayani: DO NOT have relevant financial relationships | Yejin Mok: No Answer | Kunihiro Matsushita: No Answer | Lawrence Appel: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Poster Session 1: TAC Competition and Reception

Thursday, 09/05/2024 , 05:30PM - 07:00PM

TAC Poster Session Competition

More abstracts on this topic:
Leveraging Electronic Health Records to Assess Neighborhood Advantages and Risk of Cardiovascular Outcomes Among Hypertensive Patients

Lu Yuan, Xin Xin, Kim Chungsoo, Asher Jordan, Krumholz Harlan, Brush John

Are Home Blood Pressure Devices Accurate? A Systematic Review of the Evidence

Hiremath Swapnil, Sterling Brayden, Glassman Isaac, Ruzicka Marcel

More abstracts from these authors:
Arm Size Coverage of Popular Over-the-Counter Blood Pressure Devices and Implications in US Adults

Kaur Eileen, Rayani Asma, Brady Tammy, Matsushita Kuni

Orthostatic Hypertension Does Not Alter the Effect of Intensive Blood Pressure Treatment on Cardiovascular Disease and All-Cause Mortality: An Individual-Level Meta-analysis

Juraschek Stephen, Miller Edgar, Mukamal Kenneth, Peters Ruth, Staessen Jan, Taylor Addison, Wright Jackson, Cushman William, Hu Jiun-ruey, Cluett Jennifer, Mita Carol, Lipsitz Lewis, Appel Lawrence, Beckett Nigel, Davis Barry, Holman Rury

You have to be authorized to contact abstract author. Please, Login
Not Available